LTA and colorectal cancer: Furthermore, Buhrmann et al. reported that RES can downregulate TNF-β-induced colorectal cancer cell (HCT116) proliferation by blocking TNF-β/TNF-β-receptor-induced NF-κB activation, resulting in activation of caspase-3 cleavage [67].